Lifecore Biomedical, Inc.
LFCR
$4.93
-$0.05-1.00%
NASDAQ
| 03/31/2026 | 09/30/2025 | 05/25/2025 | 05/25/2025 | 02/23/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 5.31% | 0.47% | 0.47% | 7.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 5.31% | 0.47% | 0.47% | 7.23% |
| Cost of Revenue | -- | 10.29% | 2.50% | 2.50% | -2.74% |
| Gross Profit | -- | -4.06% | -3.71% | -3.71% | 34.71% |
| SG&A Expenses | -- | -7.55% | 12.03% | 12.03% | 10.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 3.64% | 4.80% | 4.80% | 1.20% |
| Operating Income | -- | 32.49% | -134.47% | -134.47% | 46.13% |
| Income Before Tax | -- | -654.87% | -506.50% | -506.50% | -122.28% |
| Income Tax Expenses | -- | 472.86% | -76.50% | -76.50% | -110.00% |
| Earnings from Continuing Operations | -- | -668.69% | -514.93% | -514.93% | -116.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -99.24% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -596.83% | -422.29% | -422.29% | -121.19% |
| EBIT | -- | 32.49% | -134.47% | -134.47% | 46.13% |
| EBITDA | -- | 118.52% | -154.59% | -154.59% | 97.02% |
| EPS Basic | -- | -582.76% | -431.05% | -431.05% | -118.57% |
| Normalized Basic EPS | -- | -293.15% | -303.05% | -303.05% | -640.02% |
| EPS Diluted | -- | -2,219.60% | -676.98% | -676.98% | -75.87% |
| Normalized Diluted EPS | -- | -433.62% | -414.33% | -414.33% | -4,848.85% |
| Average Basic Shares Outstanding | -- | 19.16% | 14.23% | 14.23% | 9.46% |
| Average Diluted Shares Outstanding | -- | 8.45% | 3.93% | 3.93% | -0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |